BPC-157, a engineered peptide originally developed to manage gastrointestinal injuries in pigs , has generated considerable attention within the health community. Scientists believe it possesses impressive potential to promote tissue healing, alleviate swelling , and perhaps accelerate wound closure . While research on humans remain restricted